We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
Cap. Flow
+$305M
Cap. Flow %
3.1%
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$70.2M
2
SRE icon
Sempra
SRE
+$62.5M
3
LNC icon
Lincoln National
LNC
+$62.2M
4
XL
XL Group Ltd.
XL
+$60.6M
5
NEE icon
NextEra Energy
NEE
+$58.5M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Industrials 12.89%
3 Consumer Discretionary 12.47%
4 Healthcare 10.29%
5 Technology 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMTV
1276
DELISTED
Hemisphere Media Group, Inc.
HMTV
$262K ﹤0.01%
20,000
NAUH
1277
DELISTED
National American University Holdings, Inc.
NAUH
$261K ﹤0.01%
275,000
PFIS icon
1278
Peoples Financial Services
PFIS
$704M
$259K ﹤0.01%
5,500
AINC
1279
DELISTED
Ashford Inc.
AINC
$259K ﹤0.01%
4,000
KONA
1280
DELISTED
Kona Grill, Inc.
KONA
$259K ﹤0.01%
110,200
BCRH
1281
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$257K ﹤0.01%
23,300
BCO icon
1282
Brink's
BCO
$4.88B
$255K ﹤0.01%
3,200
-16,100
-83% -$1.22M
AST
1283
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$251K ﹤0.01%
186,254
+34,400
+23% +$52.7K
APAM icon
1284
Artisan Partners
APAM
$2.79B
$250K ﹤0.01%
8,300
SFE
1285
DELISTED
Safeguard Scientifics, Inc.
SFE
$250K ﹤0.01%
19,500
ATH
1286
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$250K ﹤0.01%
5,700
NOVN
1287
DELISTED
Novan, Inc. Common Stock
NOVN
$243K ﹤0.01%
8,269
+6,000
+264% +$182K
FNJN
1288
DELISTED
Finjan Holdings, Inc.
FNJN
$240K ﹤0.01%
70,700
EBMT icon
1289
Eagle Bancorp Montana
EBMT
$187M
$237K ﹤0.01%
12,289
WMS icon
1290
Advanced Drainage Systems
WMS
$10.6B
$237K ﹤0.01%
+8,300
New +$222K
ESIO
1291
DELISTED
Electro Scientific Industries
ESIO
$237K ﹤0.01%
15,000
-15,000
-50% -$282K
NCOM
1292
DELISTED
National Commerce Corporation
NCOM
$232K ﹤0.01%
5,000
SRNE
1293
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$227K ﹤0.01%
31,500
FSB
1294
DELISTED
Franklin Financial Network, Inc.
FSB
$226K ﹤0.01%
+6,000
New +$212K
XELB icon
1295
Xcel Brands
XELB
$7.27M
$224K ﹤0.01%
9,520
+420
+5% +$11.5K
NOTV
1296
DELISTED
Inotiv
NOTV
$223K ﹤0.01%
135,110
ASCMA
1297
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$221K ﹤0.01%
78,700
+38,400
+95% +$107K
AMPE
1298
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$220K ﹤0.01%
+333
New +$249K
DALN
1299
DELISTED
DallasNews
DALN
$218K ﹤0.01%
11,596
ACNB icon
1300
ACNB Corp
ACNB
$656M
$215K ﹤0.01%
+6,300
New +$196K

Similar funds

Bridgeway Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.

  • Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
  • Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
  • Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
  • Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
  • Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
  • Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.